Published February 28, 2024 | Version https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue2,Article98.pdf
Journal article Open

A Prospective Study of Heart Rate Variability and Serum Uric Acid with Blood Pressure in Normotensives and Stage 1 Hypertensives

  • 1. Assistant Professor, Department of Physiology, KBNU Foms
  • 2. Professor, Department of Respiratory Medicine, KBNU Forms

Description

Blood pressure is the pressure exerted by the moving blood column on the walls of the arteries. It is one of the vital parameters of a human being. Being a vital parameter, it is essential for the survival of human life. The blood pressure in a human undergoes multiple changes over different stages of life. At birth it is around 70/50 mmHg. Then it gradually increases to about 90/60 mmHg at the end of first year of life. Materials & Methods: This study was conducted in the private clinic, Kalaburagi, A total of 120 subjects in the age group of 30 – 40 years attending Noncommunicable diseases OPD. Among them 60 subjects were normotensives with systolic blood pressure < 130 mm Hg and diastolic blood pressure < 80 mm Hg. Result: The mean value of LF in hypertensives (348.77±325.90) is statistically more than the mean value of normotensives (216.15±249.78) with ‘t’ value of 2.50 and a ‘p’ value of 0.014 (p<0.05). This signifies that the low frequency component is significantly Conclusion: Hypertension is a noncommunicable disease, and its incidence is increasing drastically all around the world. Consequently, the need for complete understanding of the pathophysiology of the disease and proper diagnostic and therapeutic measures to counteract the disease burden has also increased.

 

 

Abstract (English)

Blood pressure is the pressure exerted by the moving blood column on the walls of the arteries. It is one of the vital parameters of a human being. Being a vital parameter, it is essential for the survival of human life. The blood pressure in a human undergoes multiple changes over different stages of life. At birth it is around 70/50 mmHg. Then it gradually increases to about 90/60 mmHg at the end of first year of life. Materials & Methods: This study was conducted in the private clinic, Kalaburagi, A total of 120 subjects in the age group of 30 – 40 years attending Noncommunicable diseases OPD. Among them 60 subjects were normotensives with systolic blood pressure < 130 mm Hg and diastolic blood pressure < 80 mm Hg. Result: The mean value of LF in hypertensives (348.77±325.90) is statistically more than the mean value of normotensives (216.15±249.78) with ‘t’ value of 2.50 and a ‘p’ value of 0.014 (p<0.05). This signifies that the low frequency component is significantly Conclusion: Hypertension is a noncommunicable disease, and its incidence is increasing drastically all around the world. Consequently, the need for complete understanding of the pathophysiology of the disease and proper diagnostic and therapeutic measures to counteract the disease burden has also increased.

 

 

Files

IJPCR,Vol16,Issue2,Article98.pdf

Files (708.8 kB)

Name Size Download all
md5:afc1faeffed7ac360b15788364086122
708.8 kB Preview Download

Additional details

Dates

Accepted
2024-02-15

References

  • 1. Kliegman, Stanton, Geme S, Schor. The Newborn. In: Nelson Textbook of Pediatrics. 1st south asian ed. 490–1. 2. Himmelfarb CD, Stafford RS, D PH. 2017 ACC / AHA / AAPA / ABC / ACPM / AGS / APhA / ASH / ASPC / NMA / PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. 2018;71(19) 3. Wu J-S, Lu F-H, Yang Y-C, Lin T-S. Epidemiological Study on The Effect of Pre-Hypertension and Family History of Hypertension on Cardiac Autonomic Function. Hypertension. 2008;51(19). 4. Park. K. Park's Textbook of Preventive and Social Medicine. 20th edition. P.323 - 326. 5. Doris PA. Hypertension Genetics, Single Nucleotide Polymorphisms, and the Common Disease: Common Variant Hypothesis. Hypertension. 2002; 39:323- 331. 6. Ehret G. Next Steps for Gene Identification in Primary Hypertension Genomics. Hypertension. 2017; 70:695–7. 7. Shaffer F, Mccraty R, Zerr CL, Medical DVA. A healthy heart is not a metronome: an integrative review of the heart's anatomy and heart rate variability. 2014;5(September):1–19 8. Lehrer P m, Gavirtz R. Heart rate variability biofeedback: how and why does it work? Front Psychol. 2014;5(1). 9. Sztajzel J. heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system. Swiss med mkly. 2004;(134):514–22. 10. Sharma D, Paudel BH, Khadka R, Thakur D, Sapkota NK, Shah DK, et al. Time domain and frequency domain analysis of heart rate variability in elite Nepalese football players 2015; 6(09):641–6. 11. Harrison's Principles of internal medicine 21st edition. P. 2764. 12. Barrett K, Brooks H, Boitano S, Barman S. Blood as a Circulatory Fluid & the Dynamics of Blood & Lymph Flow. In: Ganong's review of Medical Physiology. 23rd ed. p. 644 13. Guyton, Hall. Dominant Role of the Kidney in Long-Term Regulation of Arterial Pressure and in Hypertension: The Integrated System for Pressure Control. In: Textbook of Medical Physiology. 12th ed. p. 230–1. 14. Koeppen BM, Stanton BA. Properties of the Vasculature. In: Berne and Levy Physiology. 5th ed. p. 359. 15. Singh JP, Larson MG, Tsuji H, Evans JC, Levy D. Reduced heart rate variability and new-onsethypertension. Hypertension. 1998; (32):293–7 16. Wu J-S, Lu F-H, Yang Y-C, Lin T-S, Huang YH. Epidemiological study on the effect of prehypertension and family history of hypertension on cardiac autonomic function. J Am Coll Cardiol. 2008;51(19):1896–901 17. Kaftan AH, Kaftan O. QT intervals and heart rate variability in hypertensive parents. Japan Hear J. 2000;41(2):173–82. 18. Havlicekova Z, Jurko A, Durdik P, Nossl S, Zelenak K, Antosova M. Cardiac autonomic control in adolescents with primary hypertension. Eur J Med Res. 2009;14(4):101–3. 19. Lin X, Wang X, Li X, Song L, Meng Z, Yang Q, et al. Gender- and age- specific differences in the association of hyperuricmia and hypertension: A cross-sectional study. Int J Endocrinol. 2019;(1):1–9.